Literature DB >> 3909738

Enzyme-linked immunosorbent assay for determination of anti-mitochondrial antibodies.

S Mouritsen, M Høier-Madsen, E J Demant, H Permin.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) has been developed for the detection of human auto antibodies to mitochondria (AMA). The ELISA was compared to the previous routine method - indirect immunofluorescence technique (IIF)--and optimized for the specific detection of patients with primary biliary cirrhosis. Sera from 72 patients with primary biliary cirrhosis, 10 sera positive for anti-cardiolipin antibodies from patients with syphilis, 9 patients with drug-induced pseudolupus erythematosus, 19 patients with non-alcoholic chronic active hepatitis, 14 patients with systemic lupus erythematosus, 20 patients with rheumatoid arthritis and 100 healthy blood-donors were examined for AMA by both methods. The nosological sensitivity for the ELISA method was comparable to the IIF. The ELISA method was accurate, precise, inexpensive and well-suited as a diagnostic screening method for AMA when primary biliary cirrhosis is suspected. Furthermore, ELISA methods require less experience of the observer than IIF.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3909738     DOI: 10.1111/j.1699-0463.1985.tb02946.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand C        ISSN: 0108-0202


  3 in total

1.  The specificity of anti-cardiolipin antibodies from syphilis patients and from patients with systemic lupus erythematosus.

Authors:  S Mouritsen; M Høier-Madsen; A Wiik; O Orum; N Strandberg Pedersen
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

2.  High prevalence of autoantibodies among Danish centenarians.

Authors:  K Andersen-Ranberg; M HØier-Madsen; A Wiik; B Jeune; L Hegedus
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

3.  High prevalence of anti-mitochondrial antibodies among patients with some well-defined connective tissue diseases.

Authors:  S Mouritsen; E Demant; H Permin; A Wiik
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.